PCN5 Real-World Incidence and Management of Adverse Events (AE) in Patients with NON-Metastatic Castrate-Resistant Prostate Cancer Receiving Apalutamide or Enzalutamide
Abstract
Authors
S. Jiang S. Corman C. Macahilig N. Kebede K. Gnanasakthy A. Hussain D. Varghese S. Appukkuttan R. Waldeck